Misbah Tahir

Mr. Tahir has served as the Chief Financial Officer since 2019. Prior to joining IGM, Mr. Tahir was with Dermira, a biotechnology company, where he served in various roles from 2014 to 2018, most recently, as Vice President, Head of Finance. Previously, he held finance and leadership positions at various biotechnology companies, including Onyx Pharmaceuticals, Human Genome Sciences and Amgen. Mr. Tahir began his career as a management consultant at the consulting firm of Oliver Wyman, formerly Mercer Management Consulting. He received a B.A. in International Relations from the University of Pennsylvania and an M.B.A. from the University of Michigan Business School.